baber/WOPTO huggingface dataset:
Patent IE-850558-L (IE)
Title: Emulsifiable concentrates containing azoles
IPC: A01N25/04
Filed: 1985-03-06
Abstract: Emulsifiable concentrates, being compatible with aqueous or non-aqueous mediums, containing from 1% to 60% w/v of a 1H-imidazole or 1H-1,2,4- triazole or an acid addition salt thereof; from 1% to 60%w/v of an emulsifying agent: and from 1% to 98% w/v of a solvent, and a process for preparing the said emulsifiable concentrates.
[EP0158374A1]
Patent IE-790645-L (IE)
Title: Filter elements
IPC: B01D24/00
Filed: 1979-08-08
Abstract: A filter assembly particularly for the filtration of compressed air and other compressed gases as well as for air and liquids is formed with a pair of porous support jackets having a filter element located therebetween and defining an inlet side. The filter element is composed of a plurality of layers of filter material having different porosities with the finely porous layer being covered, at least on its surface facing the inlet side of the filter assembly, by a less finely porous layer and the filter element is particularly characterized in that it contains active charcoal.
[US4366054A]
Patent IE-36407-L (IE)
Title: Fungitoxic and bactericidal agents
IPC: C07D/
Filed: 1972-06-08
Abstract: Fungicidal and bactericidal compositions comprising, and methods of combating fungi and bacteria using 3-azolylpropynes of the general formula IN WHICH R1 is hydrogen, chlorine, bromine, iodine, alkyl, an optionally substituted aryl, aryloxyalkyl, arylthioalkyl, arylaminoalkyl or arylalkylaminoalkyl group, alkoxyalkyl, alkylmercaptoalkyl, alkylaminoalkyl, or dialkylaminoalkyl wherein the two alkyl radicals of the dialkylamino moiety may form, with the amine nitrogen atom, a five-membered to seven-membered ring that may contain at least one further hetero-atom or hetero-group, R2 is alkyl, optionally substituted cycloalkyl or optionally substituted aryl, R3, R4 and R5 each independently is hydrogen, alkyl, alkoxy, alkylmercapto or an electronegative substituent, and Az represents an optionally substituted five-membered heterocyclic radical containing one or more nitrogen atoms, OR THEIR SALTS.
[US3832466A]
Patent IE-790953-L (IE)
Title: Process for chlorination of alpha-aminoacids
IPC: C07C51/60
Filed: 1979-08-08
Abstract: A process for the chlorination of the carboxylic group of alpha -aminoacids is described whereby an aminoacid (e.g. p-hydroxy-phenyl-glycine) is suspended in an anhydrous solvent such as dioxane and treated with a chlorinating agent of the formula:  in the presence of HCl in excess. The preferred chlorinating agent is chloromethylene-dimethylammonium chloride. (From US4272454 A) [GB2020649A]
Patent IE-890969-L (IE)
Title: Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines
IPC: C07D473/18
Filed: 1989-03-29
Abstract: Antiviral activity is exhibited by compounds having the formula <CHEM> and its pharmaceutically acceptable salts wherein R1 is <CHEM> <CHEM> wherein R2 is hydrogen, methyl, fluoro, chloro, bromo, iodo, hydroxy or amino; R3 is fluoro, chloro, bromo, iodo, hydrogen, methyl, trifluoromethyl, ethyl, n-propyl, 2-fluoroethyl, 2-chloroethyl, or <CHEM> wherein R4 is chloro, bromo, iodo, hydrogen methyl or trifluoromethyl; R5 is alkyl; R6 is hydrogen, alkyl, substituted alkyl, or aryl; and R7 and R8 are independently hydrogen, -PO3H2 or - @-R6.
[EP0335355A2]
Patent IE-35485-L (IE)
Title: Coating glass fibres
IPC: D06M23/10
Filed: 1971-08-03
Abstract: 1368061 Coating glass fibres IMPERIAL CHEMICAL INDUSTRIES Ltd 5 Aug 1971 [5 Aug 1970 30 March 1971] 37801/70 and 8165/71 Heading D1P [Also in Divisions B2 and B5] A process of producing a continuous or discontinuous polymer coating on a glass fibre comprises (i) applying to the glass fibre a dispersion of film-forming polymer in an organic liquid in which the polymer is insoluble, the dispersion having been prepared by polymerising a monomer in an organic liquid to form a disperse polymer insoluble in the liquid, in the presence in the liquid of a stabiliser which is a block or graft copolymer containing at least two types of polymeric component, one type of component being solvated by the liquid and another type of component of different polarity being relatively non-solvated and associated with the disperse polymer particles, and (ii) removing the organic liquid from the fibre. The glass fibre, which may be of fused silica or of lime-alumina-boro-silicate, may be in the form of an individual filament, a plurality of filaments drawn together, or a strand. The dispersion may be applied to the fibre by spraying, immersion or padding. The treated fibre may be freed from organic liquid at one temperature and then heated at a second higher temperature, e.g. up to 350C to coalesce the polymer. The glass fibre may be pre-treated with an aqueous dispersion of poly (vinyl acetate) and a coupling, agent, e.g. an organosilane for improving adhesion between the fibre surface and the polymer coating. Alternatively the dispersion may contain the coupling agent, either as a separate component or as a group present in the solvated component of the stabiliser. The organic liquid may comprise an aliphatic or aromatic hydrocarbon. The disperse polymer may comprise an addition polymer such as polyvinyl chloride, polyethylene or polypropylene, or a condensation polymer such as a polyamide or a saturated or unsaturated polyester. The condensation polymer may be cross-linkable. The organic liquid in which the polymer dispersion is made may be modified for the treatment of the fibre by adding to it, after the preparation of the dispersion, one or more other liquids miscible therewith, e.g. a coalescing solvent or swelling agent for the polymer. Specifications 1,122,397, 1,095,932, 1,095,931 and 941,305 are referred to. Specification 1,268,132 is disclaimed.
[GB1368061A]
Patent FI-822953-L (FI)
Inventor: IIZUKA KINJI
IPC: A61K31/195
Filed: 1982-08-25
Abstract: The present invention provides an improved method for producing a nuclear substituted cinnamoylanthranilic acid compound. Illustrative of the process is the reaction of 3,4-dimethoxybenzaldehyde with 2-carboxymalonanilic acid in an inert solvent medium in the presence of piperidine to provide an intermediate salt precipitate, and the salt is treated with an acidic reagent to yield N-(3,4-dimethoxycinnamoyl)anthranilic acid product.
Patent IE-791098-L (IE)
Title: Lactam terpolymer membranes
IPC: B01D71/56
Filed: 1979-08-08
Abstract: Permselective membranes are provided consisting of lactam-polyol-polyacyl lactam block terpolymers having from 35 to 75% by weight polylactam blocks and 25 to 65% by weight polyalkylene ether blocks. The membranes are particularly suitable as blood dialysis membranes having improved permeability to solutes in the medium range of molecular weights while maintaining acceptable ultrafiltration rates and permeability to low molecular weight solutes. The membranes are provided both as planar films and hollow fibers, have high hydrolytic stability under hot wet sterilization conditions and good mechanical properties under hemodialysis conditions.
[US4181606A]
Patent IE-851152-L (IE)
Title: Immunoassay
IPC: G01N33/576
Filed: 1985-05-09
Abstract: A biotin-antibiotin immunoassay comprises coating a solid phase with a ligand-specific binding material, reacting the solid phase with a test sample, reacting the solid phase with the biotin-labeled form of the ligand-specific binding material and antibiotin labeled with a suitable marker. The marker is then measured to detect the amount of ligand present in the test sample.
Patent IE-33553-L (IE)
Title: Dual-chamber injector.
IPC: A61M5/19
Filed: 1969-08-28
Abstract: A dual-chamber liquid-injecting device includes a powder loaded piston-type syringe attached to a liquid container by a connecting member. The connecting member has an inner sleeve sliding within an outer sleeve with opposite ends of the sleeves coupling the neck of the container to the nozzle of the syringe. Ports on the inner sleeve are sealed within the outer sleeve in a preliminary extended position, and they are opened when the sleeves are pushed together or contracted to communicate the syringe with the container. The contents of the container are then drawn into the syringe. The connecting member is screwed to the neck of the container and attached to the nozzle of the syringe by a snap-fit connection on the inner sleeve. This facilitates ready detachment of the syringe from the connecting member and container for application. Locating stops for the different positions of the sleeves are provided by annular ridges between the sleeves or a cap on an internal boss within the outer sleeve, which also acts as a seal. The cap is automatically pushed off into the container when the connector is pushed together.[US3610297A]
Patent IE-35977-L (IE)
Title: Light-protected lamina.
IPC: D06N7/06
Filed: 1970-12-09
Abstract: A laminate is made using an aminoplast resin as adhesive and as light stabiliser a stilbene sulphonic acid salt of formula: (where R1 and R2 are NH2, NH-C2H4OH or N-(C2H4OH)2; R3 is a 3-substd. 1,2,4-triazole ring and X is H, alkali metal or ammonium. The aminoplast is pref. a melamine resin which may be mixed with polyvalent alcohols and/or polyvinyl alcohol under conditions such that no precondensation occurs. The laminate may be based on paper or fleece and used to make chipboard, plywood, etc.
[DE1961590A1]
Patent IE-821826-L (IE)
Title: Tamper-proof document
IPC: G03C1/76
Filed: 1982-07-29
Abstract: The tamper-proof document consists of a photographic material as information carrier comprising front- and back gelatine layers, the outer of the gelatine layers of which contain particles of a homo- or copolymer of an acrylic and/or methacrylic acid ester. The information carrier is laminated on one or both sides to a transparent foil by means of a hardenable adhesive. The document is remarkably safe against falsification.
Patent IE-832182-L (IE)
Title: Fungicidal agents
IPC: A01N47/44
Filed: 1983-09-16
Abstract: 1. Fungicidal agent, characterized in that it contains an active compound combination of special 1,2,4-triazolyl-alkanols of the formula  see diagramm : EP0166463,P5,F3  in which X represents chlorine or phenyl, and (A) dodecylguanidine acetate, the weight ratio of 1,2,4-triazolealkanols of the formula (I) to the active compound dodecylguanidine acetate being between 1:0.1 and 1:500.
Patent IE-882392-L (IE)
Title: Printing process
IPC: A61K9/24
Filed: 1988-06-16
Abstract: In the printing pad device described, the surface of the pad (20) is recessed while retaining essentially the same external form and volume. Also described is the use of the pad for at least partially coating a substrate (22) with a predetermined pattern. The substrate (22) is a printed circuit board for manufacturing integrated circuits, a component of a pharmaceutical presentation and/or dosage form, a label with raised characters, a prepolymer or similar.
Patent IE-802445-L (IE)
Title: Imidazolines
IPC: C07D233/50
Filed: 1980-11-25
Abstract: Compounds of the formula   <IMAGE>   wherein R1, R2 and R3, which may be identical to or different from each other, are each hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, hydroxyl or amino; R4 is straight or branched alkyl of 1 to 5 carbon atoms, allyl or benzyl; R5 is methyl, ethyl or 2-dimethylamino-ethyl; and n is 0 or 1; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.
Patent IE-45931-L (IE)
Title: Bacon analog.
IPC: A23D7/00
Filed: 1977-12-06
Abstract: The invention relates to a product similar to the bacon and a process for its preparation. [FR2375832A1]
Patent IE-852590-L (IE)
Title: PYRANO (2,3-b) PYRIDINES
IPC: C07D491/052
Filed: 1985-10-18
Abstract: 2-Phenylpyrano[2,3-b]pyridines are described herein. These compounds are active against a variety of viruses. A number of procedures can be used to prepare the compounds of this invention but, at some point, they would all make use of the cyclization of a (phenyl) (pyridyl)propanol or (phenyl) (pyridyl)propenol.
[US4588733A]
Patent IE-893640-L (IE)
Title: Cardioprotective tocopherol analogs
IPC: A61P9/00
Filed: 1989-11-13
Abstract: This invention relates to alkylamino alkylene derivatives of certain 2H-1-benzopyrans, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cellular protective properties and to their end-use application as therapeutic agents.
[EP0369874A2]
Patent NO-782461-L (NO)
Title: Framgangsmaate og apparat for framstilling av produkter av gjenvunnet gummi
Inventor: TURNER JAMES E
IPC: B29C48/38
Filed: 1978-07-17
Abstract: . Framgangsmåte, og, apparat for framstilling av produkter av gj envunnet gummi.
Patent NO-821284-L (NO)
Inventor: HAGBERG SVEN JOHAN OSKAR
IPC: A61F5/44
Filed: 1982-04-21
Abstract: A colostomy pouch comprises a main part and a space separated there from by a partition (13) and containing a filter material, such as active carbon (20). The main space is provided with an inlet aperture (11) for tightly sealing the pouch to an abdominal opening, and between said main space and said separate space there is provided an aperture (14) in the partition (13) to conduct gases from said main space to said separate space where the gases, while passing through the active carbon (20), are conducted to a gas exhausting aperture. Gas-permeable porous material (19) may be provided in connection with the aperture (14) in the partition (13) and the gas exhausting aperture.
Patent NO-832225-L (NO)
Inventor: SCHLOBOHM JOACHIM
IPC: A62B7/10
Filed: 1983-06-20
Abstract: An air escape filter apparatus for emergency use by a person comprises a filter which is contained within a filter housing which is accommodated within a half mask portion of a breathing mask which is adapted to be engaged over the nose and mouth of a person. The half mask portion includes a sleeve portion having a guide ring which engages over the filter housing and is shiftable along the filter housing while remaining in holding engagement therewith. The filter housing is of a size so that it is retainable within the half mask portion in a standby condition at which time it is substantially coextensive in length with the half mask portion so that the two elements are accommodated within a very small space. The filter is extensible at the end of the sleeve portion to free the interior of the half mask for engagement over the wearer's face in a ready condition.
Patent NO-850582-L (NO)
Inventor: STOPPELMANN GERSCHON
IPC: D21F1/00
Filed: 1985-02-14
Abstract: 1. Cloth, particularly fabric or felt for draining and drying paper webs in paper-manufacturing machines, comprising at least two lengthwise areas (A, B; C, D, E), characterized in that at least one of said lengthwise areas (A; D) is provided with a first type of binding or weave between the warp threads (7) and the weft threads (10) whereby the part of warp threads (7) passing above the weft threads (10) and facing the paper web forms a first contact surface with said paper web, and at least another lengthwise cloth area (B; C, E) is provided with a type of weave between the warp threads (7) and the weft threads (10) which differs from the first type of weave and whereby the part of warp threads (7) passing above the weft threads (10) and facing the web paper forms a contact surface therewith which differs from said first contact surface.
Patent NO-852721-L (NO)
Title: Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-fenyl-2-trifluormetyl-1-3-dioksan-5-yl-heptensyre-derivater
Inventor: BREWSTER ANDREW GEORGE
IPC: C07C59/64
Filed: 1985-07-05
Abstract: Oppfinnelsen gjelder fremgangsmåte for fremstilling av nye racemiske og venstredreiende optisk aktive former av tromboxan-A-antagonisten 5(Z)-7-([2,4,5-cis]-4-o-hydroksyfenyl-2-trifluormetyl-1,3-dioksan-5-yl)-heptensyre med formel I, deres salter, farmasøytiske preparater og fremgangsmåter for deres fremstilling og utgangsforbindelser for dette. De farmasøytiske midler og deres preparater er verdifulle ved visse lunge- og karsykdommer.
Patent NO-854018-L (NO)
Inventor: SELVA ENRICO
IPC: C12P1/06
Filed: 1985-10-10
Abstract: The present invention concerns a new antibiotic substance arbitrarily denominated antibiotic A 40926 complex and its factors antibiotic A 40926 factor A antibiotic A 40926 factor B. antibiotic A 40926 factor B<sub>o</sub>, antibiotic A 40926 factor PA and antibiotic A 40926 factor PB, a process for producing them by culturing the new strain Actinomadura sp. ATCC 39727 or an A 40926 producing variant or mutant thereof and the use of these new antibiotic substances in the treatment of infectious diseases involving microorganisms susceptible to them. The antibiotic substances of the invention are glycopeptidic substances belonging to the vancomycin class or antibiotics which have binding capacity to Acyl-D-Alanyl-D-Alanine.
Patent NO-861659-L (NO)
Inventor: SMITH WALTER P
IPC: A61K/
Filed: 1986-04-28
Abstract: Pantethine and pantetheine in permanent waving operations for hair to increase waving efficiency.
Patent NO-871459-L (NO)
Inventor: WATJEN FRANK
IPC: C07D487/14
Filed: 1987-04-07
Abstract: New benzodiazepine derivatives the general formula <CHEM>  wherein  X<1> and X<2> independently are <CHEM>  or COOR<1> wherein R<1> is C1-3-alkyl, C3-5-cycloalkyl, C1-3-alkoxymethyl C1-3-hydroxyalkyl or aryl,  R<4> is hydrogen, R<5> is C1-6-alkyl or wherein R<4> and R<5> together form a 2-4 membered alkylene chain. The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, and nootropics.
Patent NO-885636-L (NO)
Inventor: HUELIN KIRK JOHN
IPC: E06B7/22
Filed: 1988-12-20
Abstract: PCT No. PCT/GB88/00299 Sec. 371 Date Aug. 3, 1989 Sec. 102(e) Date Aug. 3, 1989 PCT Filed Apr. 19, 1988 PCT Pub. No. WO88/08478 PCT Pub. Date Nov. 3, 1988.A sealable frame structure for a closable opening, such as a doorway, comprises a sub-frame (1) which is adapted to be built into an opening in a wall and a frame shroud (7) adapted to be fixed to the sub-frame. The sub-frame is U-shaped in cross-section and its web is provided with a series of holes (2) by means of which the sub-frame may be secured to the wall by anchor fixings. One limb (3) of the U-shaped frame is provided with a series of holes (4) for the reception of studs (8) welded on the frame shroud (7). A strip (9) of stainless steel or like material is secured to the other limb (5) of the subframe by means of bolts (10) and nuts (11) and the frame shroud (7) is secured to the strip (9) by screws (12) which engage in drilled and tapped holes (13) in a strip (14) of steel. An extruded strip (15) of silicone rubber having a protruding profile (16) is fitted over an edge of the strip (9) and forms a seal with the edge of a door closing the doorway. A door is also provided having a stepped edge portion extending along its upper and side edges for engagement with the sealable frame structure.
Patent NO-885684-L (NO)
Inventor: DUBE GHYSLAIN
IPC: C22B21/00
Filed: 1988-12-21
Abstract: The invention relates to a method and apparatus for treating non-ferrous metal drosses in order to recover the free metal contained therein. The dross is heated by a plasma torch (40) in a rotary furnace (10), preferably to a temperature above 800 DEG C. The plasma heating and rotary motion make it possible to recover metal from the dross without employing the conventional salt bath. This means that the gases exiting the furnace can be treated more easily to remove pollutants and the solid residues can be discarded without risk of causing environmental pollution. By controlling the speed of rotation of the furnace (10), large dross lumps can be accommodated and so the conventional grinding and screening procedure of the dross can advantageously be eliminated.
Patent NO-891336-L (NO)
Inventor: ICHII YUJI
IPC: A61K/
Filed: 1989-03-30
Abstract: A bathing preparation comprising at least one organic acid and at least one carbonate is disclosed. This bathing preparation contains fumaric acid in an amount of 20% by weight or more of the total of the organic acid and at least one highly volatile perfume. The perfume is not vaporized into the atmosphere. Therefore, the bathing preparation sustains its aroma in bath water for a long time, thus giving improved relaxant and refreshing effects.
Patent NO-902778-L (NO)
Inventor: STEIN JUDITH
IPC: D21H21/00
Filed: 1990-06-21
Abstract: A method is provided for enhancing the controlled release characteristics of paper or plastic substrates by applying onto the substrate, a UV curable mixture of an epoxysilicone, an arylonium salt catalyst, such as a diaryliodoniumhexafluoroantimonate and a controlled release additive such as a phenolpropyl-substituted methyldisiloxane or an alkylphenol, such as dodecylphenol. The treated plastic or paper substrate is then subjected to UV irradiation to effect a tack-free cure of the UV curable mixture on the substrate.
Patent NO-910972-L (NO)
Inventor: MORRIS RICHARD LEO
IPC: C02F1/26
Filed: 1991-03-12
Abstract: A liquid membrane method for removing scale deposits wherein a chelating composition is utilized. The composition used in the external and internal aqueous phases of said membrane comprises an aqueous solution having a pH of about 8 to about 14, and a polyaminopolycarboxylic acid chelant. Additionally, a catalyst or synergist is used in the external phase only. Preferred chelants comprise diethylenetriaminepentaacetic acid (DTPA) or ethylenediaminetetraacetic acid (EDTA), salts, and mixture thereof. The catalyst used in the external phase comprises a monocarboxylic acid, preferably a substituted acetic acid such as mercaptoacetic acid, hydroxyacetic acid and aminoacetic acid or an aromatic acid such as salicylic acid. When the solution containing the composition is contacted with a surface containing a scale deposit, the deposit dissolves substantially more scale quicker than heretofore possible. <IMAGE>
Patent NO-920417-L (NO)
Title: Aminosyrederivater
Inventor: BROADHURST MICHAEL JOHN
IPC: C07F9/28
Filed: 1992-01-31
Abstract: Det er beskrevet forbindelser av formel i¿ NH¿R* hvor A representerer gruppen HO-HN (a) eller (b) hvor R1 representerer hydrogen, amino, beskyttet amino, acylamino eller lavere alkyl eventuelt substituert av aryl, hydroksyl-, beskyttet hydroksyl-, amino-, beskyttet amino-, acylamino-, maleimido-, suksinimido-, naftalimido-, 2,3-dihydro-l,3-diokso-lH-benz-[d,e]- isokinol-2-yl-, karboksyl-, beskyttet karboksyl-, kar- bamoyl-, mono-(lavere alkyl)-karbamoyl-, di-(lavere alkyl)-karbamoyl-, di-(lavere alkyl)-amino-, karboksy- lavere alkanoylamino-, pyrrolidino- eller morfolino- grupper; R2 representerer hydrogen eller lavere alkyl eventuelt substituert med aryl, amino-, beskyttet amino-, di-(lavere alkyl)-amino-, guanidino-, karboksyl-, beskyttet karboksyl-, karbamoyl-, mono- (lavere alkyl)-karbamoyl-, di-(lavere alkyl)-karbamoyl-, di-(lavere alkoksy)-fosfinyl-, dihydroksyfosfinyl-, pyrrolidino-, piperidino- eller morfolinogrupper, R3 representerer hydrogen eller lavere alkyl eventuelt sub- stituert med hydroksyl, beskyttet hydroksyl, amino eller beskyttet amino; R4 representerer hydrogen-, hydroksyl-, lavere alkoksy- eller benzyloksy-grupper; og R5 representerer hydrogen eller halogen; samt deres farmasøytisk akseptable salter. Disse forbindelser er anvendelige for forebygging eller bekjempelse av degene- rative leddlidelser eller for behandling av invasive svulster, aterosklerose eller multippel sklerose. De kan fremstilles ifølge kjente metoder.